The Incubator is an integrated part of Oslo Cancer Cluster Innovation Park and located next to the Institute of Cancer Research, Oslo University Hospital (Radiumhospitalet) and Ullern Upper Secondary School. The Incubator provides a dynamic, creative and professional growth environment for scientists and start ups, as well as an inspirational campus for students with ambitions in life science.
A dedicated team offers members of the Incubator research facilities, business development services and access to an extensive international network of key investors and industrial players.
The Incubator holds 5 000 square metres of offices and laboratories including start ups, global pharma, consultants, service providers, investors and research institutions. A wide range of meeting room and auditorium facilities are available on request.
The Incubator is supported by the Norwegian government to establish health care business in Norway.
The Incubator was opened at Montebello in 2015 and is owned by Oslo Cancer Cluster, Siva, Inven2 and Radforsk.
The Oslo Cancer Cluster Incubator team offers business development services, access to an international network of key industry players, as well as help to pursue funding opportunities.
Bjørn Klem started as General Manager for the Oslo Cancer Cluster Incubator January 1st 2015.
Klem was previously Research Director in Photocure ASA and holds a Master of Science in Pharmacy from Oslo University.
In Photocure Klem has been in charge of exploratory projects including clinical development of both Metvix® and Hexvix®, which have both successfully been introduced to markets world-wide. He has also been involved in a project for treatment of HPV infection and cervical precancer that has reached phase II in clinical development.
Janne Nestvold is Laboratory Manager at Oslo Cancer Cluster Incubator.
Nestvold holds a PhD in Immunology from the Faculty of Medicine at the University of Oslo.
Her research experience is from academia and biotech within the field of immuno-oncology.
Thomas Andersson is Senior Advisor Business Development at Oslo Cancer Cluster Incubator and Oslo Cancer Cluster.
Thomas holds a Ph.D. in biophysics from Lund University and has more than 30 years of experience from establishing, operating and funding start-ups in the life science field.
Wenche Gerhardsen is responsible for internal and external communications in the cluster and incubator, including e.g. our webpages, social media, media-relations and marketing.
She has previously worked at The Norwegian Defence Research Establishment (FFI) as Senior Advisor and Communications Advisor and she has a background as a news- and science journalist. Her master’s degree is in political science. You can read more about Wenche’s background at LinkedIn.
Charlotte Wu Homme
Charlotte Wu Homme is responsible for Membership & Events for Oslo Cancer Cluster. This includes R&D network meetings, symposiums, and other initiatives for cluster members.
She has served different international organizations while posted in the U.S, Norway, and throughout Asia. These organizations include: The Economist, The World Bank, and Johns Hopkins University.
Charlotte Homme attained her Master of Science in Project Management from The George Washington University.
The Board of Oslo Cancer Cluster Incubator has extensive oncology business knowledge and experience with commersialization of research and early phase company development.
Ketil F. Widerberg, MBA, is General Manager of Oslo Cancer Cluster and Chairman of the Board of Oslo Cancer Cluster Incubator.
He builds on a long experience in realizing new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners.
Ketil has a broad operational experience ranging from explorative project management to being responsible for business development.
Widerberg’s educational background spans from preclinical medical school to management studies. He also holds a MBA from the University of Cambridge.
Ole Kristian Hjelstuen
Jónas Einarsson has served as a Board Member since 2020. Mr Einarsson has over 30 years of experience in the medical industry and is currently the CEO of Radium Hospital Research Foundation, which position he has held since 2000.
Mr Einarsson was a general practitioner and health director of the Lardal municipality from 1991 until 2000 and was general manager of Oslo
Private Hospital from 1984 until 1991.
Mr Einarsson is educated as a Medical Doctor (MD) from the Reykjavik University, Iceland and the University of Oslo, Norway.
Telephone: +47 91 84 96 86
The administration of Oslo Cancer Cluster Incubator is situated on the 4th floor in the pink part of the Oslo Cancer Cluster Innovation Park.
Please enter Oslo Cancer Cluster Innovation Park Entrance through main entrance 2A facing the Norwegian Radium Hospital. Alternative entrances 1A and 2B facing Ring3 can also be used as well as access through a car park at ground floor. Take the staircase or lift to 4th floor (pink building) and push the bell.
Schedule a visit
Contact Bjørn Klem to book your visit
Org. number: 998483506
Org. form: Public limited company (aksjeselskap)
Car or Taxi:
Ring Road 3 to the Ullernchausséen 64/66, next to the Norwegian Radium Hospital. Taxi from “Skøyen” takes only 5 minutes, this is where the Airport Express Train to Drammen stops, as well as several other trains.
▸ AIRPORT EXPRESS TRAIN travel planner.
8 minutes walking distance from the “Montebello” station served by Line no. 3 from Oslo city centre.
▸ RUTER travel planner.
Contact Team >
Oslo Cancer Cluster Incubator will support promising oncology biotechs to commercialize successfully.
The Incubator provides a dynamic, creative, and professional growth environment for scientists and start-ups.